To quarantine or not? CDC’s post-vaccine guidance for exposed workers gives nod to staff shortages
By
Alicia Lasek
Feb 12, 2021
Fully vaccinated individuals may now skip quarantine after exposure to an infected person. But that doesn’t go for healthcare workers in facility settings — except as a last option.
Coronavirus rates drop 96% in nursing homes, but some see first-ever cases in new year
By
Alicia Lasek
Mar 31, 2021
More than 430 nursing homes saw their first-ever COVID cases in early 2021, evidence that continued infection control measures are needed, and despite phenomenal declines in facility rates, says the U.S....
This season’s flu vaccinations linked to lower COVID-19 likelihood, severity
By
Alicia Lasek
Feb 24, 2021
People who received a flu vaccination were 24% less likely to test positive for COVID-19. And those who did contract the disease had a less severe course when compared with people who didn’t get a flu...
What happens once Phase 1 vaccine clinics wrap up? Ensuring access to next doses
By
Kimberly Bonvissuto
Alicia Lasek
Feb 10, 2021
Industry advocates and the CDC answer key questions: How to facilitate a smooth transition to a new vaccine supplier; and how to guarantee second doses for staff and residents who receive their first dose...
Are we there yet? Vaccination success won’t ease need for LTC vigilance, observers say
By
Alicia Lasek
Feb 18, 2021
The need for stepped-up infection control measures likely will remain a necessity for the foreseeable future, say industry observers and stakeholders.
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
COVID-19 vaccinations are essentially at a standstill in U.S. nursing homes and assisted living communities due to federal officials’ call today for a pause on the use of the Johnson & Johnson vaccine.